Beijing Shenogen Biomedical Co., Ltd

2 in Phase 3

Quick facts

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Beijing Shenogen Biomedical Co., Ltd

What is Beijing Shenogen Biomedical Co., Ltd's pipeline?

Beijing Shenogen Biomedical Co., Ltd has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include HUACHANSU PIAN, Sorafenib Tosylate Tablets.

Related